Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Shattuck Labs, Inc.
University of Nebraska
Hackensack Meridian Health
University of California, Irvine
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
Orca Biosystems, Inc.
National Cancer Institute (NCI)
Roswell Park Cancer Institute
Gamida Cell ltd
City of Hope Medical Center
Dartmouth-Hitchcock Medical Center
Bristol-Myers Squibb
Astellas Pharma Inc
Hutchmed
NextCure, Inc.
University of Colorado, Denver
National Cancer Institute (NCI)
University of Rochester
Chang Gung University
Brown University
Novartis
Vanderbilt-Ingram Cancer Center
Masonic Cancer Center, University of Minnesota
Astellas Pharma Inc
Montefiore Medical Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Thomas Jefferson University
Astellas Pharma Inc
City of Hope Medical Center
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
City of Hope Medical Center
Servier
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Thomas Jefferson University
Baylor College of Medicine
Takeda
Takeda
Therapeutic Advances in Childhood Leukemia Consortium
Novartis
AbbVie